MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody,

mbs303 MBS 303 is a bispecific antibody targeting CD3CD20 being developed by Beijing Mabworks Biotech for the treatment of B cell non-Hodgkin lymphoma. The. MBS-303: CD20CD3Beijing Mabworks Biotech Co., Ltd. ()12

mbs303, MBS303 * Melestarikan Hutan Indonesia untuk Masa Depan yang Lebih Hijau. IDR 10,000.00. MBS303 menekankan pentingnya menggunakan media sosial secara positif..